FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.

Saved in:
Bibliographic Details
Title: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.
Authors: Gombos A; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. andrea.gombos@bordet.be.; Université Libre de Bruxelles, Brussels, Belgium. andrea.gombos@bordet.be., Venet D; Université Libre de Bruxelles, Brussels, Belgium.; Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium., Ameye L; Statistical Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium., Vuylsteke P; Medical Oncology, UCLouvain, CHU Namur Site Sainte-Elisabeth, Namur, Belgium.; University of Botswana, Private Bag UB 0022, Gabarone, Botswana., Neven P; Multidisciplinary Breast Center and Department of Gynecology and Obstetrics, UZ Leuven, KU Leuven, Leuven, Belgium., Richard V; Medical Oncology CHU Ambroise Paré, Mons, Belgium., Duhoux FP; Medical Oncology Cliniques Universitaires Saint-Luc, Brussels, Belgium., Laes JF; OncoDNA, Gosselies, Belgium., Rothe F; Université Libre de Bruxelles, Brussels, Belgium.; Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium., Sotiriou C; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.; Université Libre de Bruxelles, Brussels, Belgium.; Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium., Paesmans M; Statistical Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium., Awada A; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.; Université Libre de Bruxelles, Brussels, Belgium., Guiot T; Nuclear Medicine, Institut Jules Bordet, Brussels, Belgium., Flamen P; Nuclear Medicine, Institut Jules Bordet, Brussels, Belgium., Piccart-Gebhart M; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.; Université Libre de Bruxelles, Brussels, Belgium., Ignatiadis M; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.; Université Libre de Bruxelles, Brussels, Belgium., Gebhart G; Nuclear Medicine, Institut Jules Bordet, Brussels, Belgium.
Source: NPJ breast cancer [NPJ Breast Cancer] 2021 Sep 21; Vol. 7 (1), pp. 125. Date of Electronic Publication: 2021 Sep 21.
Publication Type: Journal Article
Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2374-4677
DOI:10.1038/s41523-021-00331-8